|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
accompanying balance sheet of MGI PHARMA, INC. as of June 30, 2000, and the
related statement of operations for the six months ended June 30, 2000 and is
qualified in its entirety by reference to such financial statements:
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 14,427,294
<SECURITIES> 29,405,800
<RECEIVABLES> 4,002,619
<ALLOWANCES> 162,053
<INVENTORY> 738,278
<CURRENT-ASSETS> 48,811,736
<PP&E> 1,239,840
<DEPRECIATION> 985,735
<TOTAL-ASSETS> 50,500,709
<CURRENT-LIABILITIES> 3,526,948
<BONDS> 0
0
0
<COMMON> 46,523,761
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 50,500,709
<SALES> 10,700,377
<TOTAL-REVENUES> 13,547,723
<CGS> 697,213
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 4,029,565
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 1,573,169
<INCOME-TAX> 96,463
<INCOME-CONTINUING> 1,476,706
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,476,706
<EPS-BASIC> .10
<EPS-DILUTED> .09
</TABLE>
|
|